norharman has been researched along with Hepatocellular Carcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JJ; Huang, XX; Lin, B; Song, SJ; Wang, XB; Yao, GD; Zhao, WY; Zhou, WY | 1 |
| Dai, H; Gan, H; Gao, WJ; Ling, C; Ling, Y; Liu, J; Liu, S; Meng, C; Qian, J; Tao, J; Wu, H; Zhang, Y | 1 |
| Kawamori, T; Kitamura, T; Shibata, H; Sugimura, T; Totsuka, Y; Uchiya, N; Wakabayashi, K | 1 |
3 other study(ies) available for norharman and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Enantiomeric β-carboline dimers from Picrasma quassioides and their anti-hepatoma potential.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carbolines; Carcinoma, Hepatocellular; Cell Line, Tumor; Chromatography, High Pressure Liquid; Circular Dichroism; Dimerization; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Molecular Structure; Picrasma; Plant Stems; Spectrum Analysis; Stereoisomerism | 2019 |
β-Carboline and N-hydroxycinnamamide hybrids as anticancer agents for drug-resistant hepatocellular carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carbolines; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cinnamates; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Molecular Structure; Structure-Activity Relationship | 2019 |
Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats.
Topics: Adenocarcinoma; Aniline Compounds; Animals; beta Catenin; Carbolines; Carcinoma, Hepatocellular; Colon; Colonic Neoplasms; Cytoskeletal Proteins; Female; Genes, APC; Genes, ras; Harmine; Indoles; Leukemia; Liver; Liver Neoplasms; Male; Mutagens; Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Pyridines; Rats; Rats, Inbred F344; Thyroid Neoplasms; Trans-Activators | 2004 |